Skip to main content

Table 2 Clinical features of GRN p.V490M family patients and other pathogenic GRN missense mutations

From: A novel c.1468 G > A GRN mutation causes frontotemporal dementia in a Chinese Han family

Mutation

Family

history

Affected

(n)

Age at onset(y)

Clinical diagnosis

Clinical symptoms

CT/MRI

FDG/Aβ/Tau-PET

Pathology

PGRN plasma

level (ng/ml)

APOE

p.V490M*

Yes

3

II:2

70

Probable AD

Memory and cognitive impairment, cataphasia

H-T atrophy

N

N

N

NA

II:3

69

Probable AD

Memory loss, cognitive impairment

H–T atrophy, cortical and subcortical atrophy

N

CSF biomarkers consistent with AD

N

ε3/ε3

II:5

67

MCI

Mild cognitive impairment

Mild cortex atrophy without H

T (R)-P (L) hypo-metabolism

Aβ-PET negative

N

N

ε3/ε3

p.C139R

Yes

2

II:9

77

AD

Memory decline and impairment of instrumental activities

F–T atrophy

N

N

N

ε3/ε3

II:10

75

AD

Memory impairment, spatial and temporal disorientation, prosopagnosia

F–T atrophy(L > R)

N

Brain autopsy presented the pathologic hallmarks of AD

96

ε3/ε3

p.V500I

No

1

55

bvFTD, PSP

Vertical supranuclear

gaze palsy, rigidity

and postural tremor

of right upper limb, progressive memory deterioration

Mild cortex atrophy

Mild hypo-metabolism in bilateral frontotemporal lobe

p.V500I mutation over-expression increases apoptosis of SH-SY5Y cells

N

N

p.A324T

No

1

64

PNFA

Apraxia of speech

T-P atrophy(L > R)

N

Brain autopsy presented the pathologic hallmarks of CBD

NA

N

p.W7R

Yes

1

53

bvFTD

Behavioral change, apathy, loss of empathy, indifference, social withdrawal

F–T–P atrophy (L > R)

severe hypo-metabolism in prefrontal, orbitofrontal, cingulate cortex, temporal pole, and temporoparietal junction

The mutation leads to progranulin haploinsufficiency

41

N

  1. AD, Alzheimer’s disease; bvFTD, behavioral variant frontotemporal dementia; PNFA, progressive non-fluent aphasia; PSP, progressive supranuclear palsy; MCI, mild cognitive impairment; CBD, corticobasal degeneration; Aβ, β-Amyloid protein; CT, computed tomography; MRI, magnetic resonance imaging; FDG, F-fludeoxyglucose; PET, positron emission tomography; F, frontal;T, temporal; P, parietal; H, hippocampus; L, left; R, right; N, none; NA, Not available
  2. *Our study